LaserACE® Global Medical Director

My decision on being involved as an investigator with LaserACE® technology is threefold: (1) the ability to restore dynamic accommodation without compromise to the refractive state of the eye; (2) the lack of visual axis compromise; (3) the market potential for such a procedure on emmetropic presbyopes and/or past monofocal IOL patients is immense.  I truly am excited about continuing to pave the way for my patients to see beyond their imagination by using a technology that rejuvenates the eye’s natural power.

Mitchell A. Jackson, MD
Lake Villa, Illinois
This email address is being protected from spambots. You need JavaScript enabled to view it.

LaserACE® Clinical Study Principal Investigators

Note: LaserACE® is not yet FDA approved or available in the United States. It is currently in clinical trials only in select areas outside of the United States.

Ace Vision Group, Inc.
39655 Eureka Dr, Newark, CA 94560
Telephone: 234-738-4074

Ace Vision See Life NaturallyTM, LaserACE® and VisioLite® are registered trademarks of Ace Vision Group, Inc. All rights reserved. 2008-2019.